Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/16/2022 | Celldex Therapeutics, Inc. | CLDX | Grant | | 77k | $22.48 | $1.7M | | 06/16/2022 |
12/08/2021 | Celldex Therapeutics, Inc. | CLDX | Sale | Common Stock | 600 | $40.00 | $24k | | 12/08/2021 |
12/08/2021 | Celldex Therapeutics, Inc. | CLDX | Exercise | Incentive Stock Option (Right to Buy) | 600 | $2.78 | $1.7k | | 12/08/2021 |
11/01/2021 | Celldex Therapeutics, Inc. | CLDX | Exercise | Incentive Stock Option (Right to Buy) | 600 | $2.78 | $1.7k | | 11/01/2021 |
11/01/2021 | Celldex Therapeutics, Inc. | CLDX | Sale | Common Stock | 600 | $41.71 | $25k | | 11/01/2021 |
06/17/2021 | Celldex Therapeutics, Inc. | CLDX | Grant | | 62.5k | $28.00 | $1.8M | | 06/17/2021 |
06/18/2020 | Celldex Therapeutics, Inc. | CLDX | Grant | | 84k | $10.38 | $871.9k | | 06/18/2020 |
06/09/2020 | Celldex Therapeutics, Inc. | CLDX | Purchase | Common Stock, par value $0.001 per share | 1000 | $3.01 | $3k | | 06/09/2020 |
06/19/2019 | Celldex Therapeutics, Inc. | CLDX | Grant | | 43k | $2.78 | $119.5k | | 06/19/2019 |
06/13/2018 | Celldex Therapeutics, Inc. | CLDX | Grant | | 275k | $0.60 | $165.3k | | 06/13/2018 |